AI / Creativity 23andMe has sold the rights to develop a drug based on its users’ DNA — www.newscientist.com Consumer genomics firm 23andMe has signed its first deal to sell the rights to develop a new drug for inflammatory diseases to a pharmaceutical company
Mike's Industry View - Issue #151
Mike's Industry View - Issue #151
Mike's Industry View - Issue #151
AI / Creativity 23andMe has sold the rights to develop a drug based on its users’ DNA — www.newscientist.com Consumer genomics firm 23andMe has signed its first deal to sell the rights to develop a new drug for inflammatory diseases to a pharmaceutical company